Slingshot members are tracking this event:
NKG2A checkpoint receptor expression on tumor-infiltrating CD8+ T cells restrains efficacy of immunotherapy data expepcted April 3 2017
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|IPHYF||Community voting in process|
Slingshot Insights Explained
Apr 03, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Nkg2a Checkpoint Receptor, Cd8+ T Cells, Immunotherapy